Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

EFFECTS OF REFORMER PILATES ON FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN WOMEN

30. april 2026 oppdatert av: Ayca Sena Sensoy

THE EFFECTS OF REFORMER PILATES EXERCISES APPLIED IN WOMEN ON FUNCTIONAL CAPACITY, HEART RATE, BODY COMPOSITION AND QUALITY OF LIFE

This study aims to investigate the effects of reformer pilates exercises on functional capacity, heart rate, body composition, and quality of life in women. A total of 50 participants were initially enrolled; however, 44 participants completed the study. Participants were divided into intervention and control groups, and the intervention group performed reformer pilates exercises for 8 weeks.

Studieoversikt

Detaljert beskrivelse

The aim of this study is to investigate the effects of reformer pilates exercises applied in women on functional capacity, heart rate, body composition, and quality of life. A total of 50 healthy adult women were initially included in the study. Due to dropouts related to non-attendance, 44 participants completed the study and were analyzed, with 22 participants in the intervention group and 22 in the control group. The intervention group participated in a reformer pilates exercise program twice a week for 8 weeks, while the control group followed a home-based exercise program. Functional capacity was assessed using the 6-minute walk test. Heart rate was measured only in the intervention group at the 20th minute of the exercise session using a fingertip pulse oximeter. Body composition was evaluated using bioelectrical impedance analysis. Quality of life was assessed using the SF-12 questionnaire. All measurements were performed at baseline and after 8 weeks.

Studietype

Intervensjonell

Registrering (Faktiske)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Istanbul
      • Istanbul, Istanbul, Tyrkia (Türkiye), 34000
        • Istanbul Aydin University- FLC Concept Healthy Living Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Female participants aged between 20 and 40 years
  • Healthy individuals capable of performing exercise
  • Voluntary participation in the study
  • Ability to attend Pilates sessions regularly

Exclusion Criteria:

  • Male participants
  • Receiving any form of physical therapy intervention
  • History of surgery
  • Severe spinal pathologies
  • Neurological disorders
  • Cardiopulmonary diseases

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Reformer Pilates Group
Participants received supervised reformer pilates exercises twice a week for 8 weeks.
Participants performed supervised reformer pilates exercises twice a week for 8 weeks.
Annen: Control Group
Participants followed a home-based exercise program twice a week for 8 weeks without supervised reformer pilates.
Participants performed a home-based exercise program on their own for 8 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Functional Capacity (6-Minute Walk Test)
Tidsramme: At baseline and after 8 weeks
Functional capacity will be assessed using the 6-minute walk test (6MWT). The distance walked in meters (m) will be recorded.
At baseline and after 8 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Quality of Life (Short Form-12, SF-12)
Tidsramme: At baseline and after 8 weeks
Quality of life will be assessed using the Short Form-12 (SF-12) questionnaire. Physical Component Summary (PCS) and Mental Component Summary (MCS) scores will be calculated. Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
At baseline and after 8 weeks
Body Fat Percentage (%)
Tidsramme: At baseline and after 8 weeks
Body fat percentage (%) will be assessed using bioelectrical impedance analysis (BIA, InBody device).
At baseline and after 8 weeks
Heart Rate (beats per minute, bpm)
Tidsramme: At baseline and after 8 weeks
Heart rate was measured using a pulse oximeter at the 20th minute of the exercise session only in the intervention group, both at the first session and at the end of 8 weeks.
At baseline and after 8 weeks
Skeletal Muscle Mass (kg)
Tidsramme: At baseline and after 8 weeks
Skeletal muscle mass (kg) will be assessed using bioelectrical impedance analysis (BIA) with an InBody device under standardized conditions.
At baseline and after 8 weeks
Body Weight (kg)
Tidsramme: At baseline and after 8 weeks
Body weight (kg) will be assessed using bioelectrical impedance analysis (BIA) with an InBody device under standardized conditions.
At baseline and after 8 weeks
Body Mass Index (kg/m²)
Tidsramme: At baseline and after 8 weeks
Body mass index (kg/m²) will be calculated as body weight (kg) divided by height squared (m²). Body weight will be obtained using bioelectrical impedance analysis (BIA) with an InBody device.
At baseline and after 8 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Ayca S Sensoy, PT, MSc Student, Istanbul Aydın University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. november 2025

Primær fullføring (Faktiske)

19. februar 2026

Studiet fullført (Faktiske)

19. februar 2026

Datoer for studieregistrering

Først innsendt

13. april 2026

Først innsendt som oppfylte QC-kriteriene

30. april 2026

Først lagt ut (Faktiske)

6. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. april 2026

Sist bekreftet

1. april 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 268/2025

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared due to privacy and ethical considerations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere